Trial Profile
Phase 4 multi-center, randomized, double blind, placebo-controlled study of H.P. Acthar® Gel (Repository Corticotropin Injection) for Symptomatic Sarcoidosis
Status:
Planning
Phase of Trial:
Phase IV
Latest Information Update: 11 Oct 2017
Price :
$35
*
At a glance
- Drugs Corticotropin (Primary)
- Indications Sarcoidosis
- Focus Adverse reactions
- 11 Oct 2017 New trial record